|
1
|
Chu EA and Kim YJ: Laryngeal cancer:
Diagnosis and preoperative work-up. Otolaryngol Clin North Am.
41:673–695, v. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu HC, Chen GG, Vlantis AC, Tong MC and
van Hasselt CA: Chemotherapy for laryngeal cancer - an apoptotic
approach. Curr Drug Targets. 9:878–886. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bar-Ad V, Palmer J, Yang H, Cognetti D,
Curry J, Luginbuhl A, Tuluc M, Campling B and Axelrod R: Current
management of locally advanced head and neck cancer: The
combination of chemotherapy with locoregional treatments. Semin
Oncol. 41:798–806. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang GL, Jiang BH, Rue EA and Semenza GL:
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension. Proc Natl
Acad Sci USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wohlkoenig C, Leithner K, Deutsch A,
Hrzenjak A, Olschewski A and Olschewski H: Hypoxia-induced
cisplatin resistance is reversible and growth rate independent in
lung cancer cells. Cancer Lett. 308:134–143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoshiba S, Ito D, Nagumo T, Shirota T,
Hatori M and Shintani S: Hypoxia induces resistance to
5-fluorouracil in oral cancer cells via G(1) phase cell cycle
arrest. Oral Oncol. 45:109–115. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang L, Ao Q, Zhang Q, Yang X, Xing H, Li
F, Chen G, Zhou J, Wang S, Xu G, et al: Hypoxia induced paclitaxel
resistance in human ovarian cancers via hypoxia-inducible factor
1alpha. J Cancer Res Clin Oncol. 136:447–456. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li DW, Dong P, Wang F, Chen XW, Xu CZ and
Zhou L: Hypoxia induced multidrug resistance of laryngeal cancer
cells via hypoxia-inducible factor-1α. Asian Pac J Cancer Prev.
14:4853–4858. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li DW, Gao S, Shen B and Dong P: Effect of
apoptotic and proliferative indices, P-glycoprotein and survivin
expression on prognosis in laryngeal squamous cell carcinoma. Med
Oncol. 28(Suppl 1): S333–S340. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li L, Jiang AC, Dong P, Wan Y and Yu ZW:
The characteristics of Hep-2 cell with multiple drug resistance
induced by Taxol. Otolaryngol Head Neck Surg. 137:659–664. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhigang H, Qi Z, Jugao F, Xiaohong C, Wei
Z, Hong W, Hu H, Na M, Zheng Y and Demin H: Reverse multidrug
resistance in laryngeal cancer cells by knockdown MDR1 gene
expression. J Otolaryngol Head Neck Surg. 38:440–448.
2009.PubMed/NCBI
|
|
12
|
Xie J, Li DW, Chen XW, Wang F and Dong P:
Expression and significance of hypoxia-inducible factor-1α and
MDR1/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2
cells. Oncol Lett. 6:232–238. 2013.PubMed/NCBI
|
|
13
|
Sowter HM, Raval RR, Moore JW, Ratcliffe
PJ and Harris AL: Predominant role of hypoxia-inducible
transcription factor (Hif)-1alpha versus Hif-2alpha in regulation
of the transcriptional response to hypoxia. Cancer Res.
63:6130–6134. 2003.PubMed/NCBI
|
|
14
|
Li DW, Zhou L, Jin B, Xie J and Dong P:
Expression and significance of hypoxia-inducible factor-1α and
survivin in laryngeal carcinoma tissue and cells. Otolaryngol Head
Neck Surg. 148:75–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ludescher C, Thaler J, Drach D, Drach J,
Spitaler M, Gattringer C, Huber H and Hofmann J: Detection of
activity of P-glycoprotein in human tumour samples using rhodamine
123. Br J Haematol. 82:161–168. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu H, Chen XP, Luo SF, Guan J, Zhang WG
and Zhang BX: Involvement of hypoxia-inducible factor-1-alpha in
multidrug resistance induced by hypoxia in HepG2 cells. J Exp Clin
Cancer Res. 24:565–574. 2005.PubMed/NCBI
|
|
18
|
Liu L, Ning X, Sun L, Zhang H, Shi Y, Guo
C, Han S, Liu J, Sun S, Han Z, et al: Hypoxia-inducible factor-1
alpha contributes to hypoxia-induced chemoresistance in gastric
cancer. Cancer Sci. 99:121–128. 2008.PubMed/NCBI
|
|
19
|
Huang C, Xu D, Xia Q, Wang P, Rong C and
Su Y: Reversal of P-glycoprotein-mediated multidrug resistance of
human hepatic cancer cells by Astragaloside II. J Pharm Pharmacol.
64:1741–1750. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hao YX, He ZW, Zhu JH, Shen Q, Sun JZ, Du
N and Xiao WH: Reversal of multidrug resistance in renal cell
carcinoma by short hairpin RNA targeting MDR1 gene. Chin Med J
(Engl). 125:2741–2745. 2012.PubMed/NCBI
|
|
21
|
Jia M, Hu J, Li W, Su P, Zhang H, Zhang X
and Zhou G: Trps1 is associated with the multidrug resistance of
osteosarcoma by regulating MDR1 gene expression. FEBS Lett.
588:801–810. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wartenberg M, Ling FC, Müschen M, Klein F,
Acker H, Gassmann M, Petrat K, Pütz V, Hescheler J and Sauer H:
Regulation of the multidrug resistance transporter P-glycoprotein
in multicellular tumor spheroids by hypoxia-inducible factor
(HIF-1) and reactive oxygen species. FASEB J. 17:503–505.
2003.PubMed/NCBI
|
|
23
|
Xia S, Yu SY, Yuan XL and Xu SP: Effects
of hypoxia on expression of P-glycoprotein and multidrug resistance
protein in human lung adenocarcinoma A549 cell line. Zhonghua Yi
Xue Za Zhi. 84:663–666. 2004.(In Chinese). PubMed/NCBI
|
|
24
|
Song X, Liu X, Chi W, Liu Y, Wei L, Wang X
and Yu J: Hypoxia-induced resistance to cisplatin and doxorubicin
in non-small cell lung cancer is inhibited by silencing of
HIF-1alpha gene. Cancer Chemother Pharmacol. 58:776–784. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kimura Y, Matsuo M, Takahashi K, Saeki T,
Kioka N, Amachi T and Ueda K: ATP hydrolysis-dependent multidrug
efflux transporter: MDR1/P-glycoprotein. Curr Drug Metab. 5:1–10.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ueda K: Molecular mechanisms for drug
transport by MDR1/P-glycoprotein. Tanpakushitsu Kakusan Koso.
42:1263–1272. 1997.(In Japanese). PubMed/NCBI
|
